MedTrace Logo

Global Burden and Treatment Trajectiories in Italian Patients With Fabry Disease

NCT04916977 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2023-11-28

No results posted yet for this study

Summary

GROUND study is an Italian, multicenter retrospective longitudinal cohort study with a cross-sectional phase with the aim to quantify the severe clinical burden in terms of severe and fatal outcomes and extension of clinical impairment in the Italian Fabry Disease patients' population

Conditions

Interventions

OTHER

FD patients

Patients with Fabry disease diagnosis

Sponsors & Collaborators

  • Chiesi Italia

    lead INDUSTRY

Principal Investigators

  • Antonio Pisani, MD · Università degli Studi di Napoli "Federico II" NAPOLI

  • Federico Pieruzzi, MD · Ospedale San Gerardo MONZA

  • Renzo Mignani, MD · AUSL della Romagna - Ospedale Infermi RIMINI

  • Elena Verrecchia, MD · Fondazione Policlinico Universitario "Gemelli" IRCCS ROMA

  • Davide Noto, MD · A.O.U. Policlinico "Giaccone" PALERMO

  • Antonino Tuttolomondo, MD · A.O.U. Policlinico "Giaccone" PALERMO

  • Maurizio Pieroni, MD · AUSL Toscana Sud-Est - Ospedale San Donato AREZZO

  • Iacopo Olivotto, MD · A.O.U. Careggi FIRENZE

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-23
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Italy

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04916977 on ClinicalTrials.gov